CA Stock MarketDetailed Quotes

ONC Oncolytics Biotech Inc

Watchlist
  • 1.330
  • -0.050-3.62%
15min DelayTrading Nov 29 11:25 ET
102.51MMarket Cap-3694P/E (TTM)

Oncolytics Biotech Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-10.40%9.9M
10.61%7.92M
29.58%8.73M
25.51%33.79M
4.01%8.85M
82.31%11.05M
18.43%7.16M
6.72%6.73M
2.63%26.92M
14.13%8.51M
Selling and administrative expenses
-40.71%3.11M
-2.80%3.36M
-6.64%2.98M
41.25%15.68M
6.20%3.79M
129.19%5.24M
26.06%3.46M
22.79%3.2M
-13.71%11.1M
7.32%3.57M
-General and administrative expense
-40.71%3.11M
-2.80%3.36M
-6.64%2.98M
41.25%15.68M
6.20%3.79M
129.19%5.24M
26.06%3.46M
22.79%3.2M
-13.71%11.1M
7.32%3.57M
Research and development costs
16.92%6.79M
23.16%4.56M
62.28%5.74M
14.76%17.71M
-3.80%4.66M
57.99%5.81M
15.51%3.7M
-4.56%3.54M
19.44%15.43M
31.61%4.84M
Depreciation amortization depletion
----
----
----
2.81%403K
----
----
----
----
-13.27%392K
--99K
-Depreciation and amortization
----
----
----
2.81%403K
----
----
----
----
-13.27%392K
--99K
Operating profit
10.40%-9.9M
-10.61%-7.92M
-29.58%-8.73M
-25.51%-33.79M
-4.01%-8.85M
-82.31%-11.05M
-18.43%-7.16M
-6.72%-6.73M
-2.63%-26.92M
-14.13%-8.51M
Net non-operating interest income (expenses)
-14.43%261K
27.34%340K
68.30%446K
151.14%1.33M
55.73%489K
108.90%305K
444.90%267K
1,372.22%265K
433.33%528K
1,292.89%314K
Non-operating interest income
-14.43%261K
27.34%340K
68.30%446K
151.14%1.33M
55.73%489K
108.90%305K
444.90%267K
1,372.22%265K
433.33%528K
1,292.89%314K
Other net income (expenses)
-87.03%107K
183.63%419K
4,231.25%1.39M
192.40%4.81M
1,569.97%4.45M
-45.29%825K
-154.05%-501K
106.57%32K
1,482.35%1.65M
-9.48%-303K
Gain on sale of security
-87.03%107K
183.63%419K
4,231.25%1.39M
192.40%4.81M
1,569.97%4.45M
-45.29%825K
-154.05%-501K
106.57%32K
1,482.35%1.65M
-9.48%-303K
Income before tax
3.90%-9.53M
3.15%-7.16M
-7.10%-6.89M
-11.73%-27.66M
54.03%-3.91M
-125.10%-9.92M
-45.84%-7.39M
5.04%-6.44M
5.73%-24.75M
-10.22%-8.5M
Income tax
71.43%12K
102.13%95K
15.48%97K
-24.56%43K
250.00%7K
88.00%47K
71.43%84K
36.20%57K
Earnings from equity interest net of tax
Net income
3.85%-9.54M
2.49%-7.26M
-7.10%-6.89M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
5.58%-24.84M
-10.36%-8.55M
Net income continuous operations
3.85%-9.54M
2.49%-7.26M
-7.10%-6.89M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
5.58%-24.84M
-10.36%-8.55M
Noncontrolling interests
Net income attributable to the company
3.85%-9.54M
2.49%-7.26M
-7.10%-6.89M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
5.58%-24.84M
-10.36%-8.55M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
3.85%-9.54M
2.49%-7.26M
-7.10%-6.89M
-11.75%-27.75M
53.83%-3.95M
-125.16%-9.93M
-46.05%-7.44M
5.04%-6.44M
5.58%-24.84M
-10.36%-8.55M
Diluted earnings per share
14.29%-0.12
16.67%-0.1
10.00%-0.09
4.65%-0.41
66.67%-0.05
-75.00%-0.14
-33.33%-0.12
16.67%-0.1
12.24%-0.43
-7.14%-0.15
Basic earnings per share
14.29%-0.12
16.67%-0.1
10.00%-0.09
4.65%-0.41
66.67%-0.05
-75.00%-0.14
-33.33%-0.12
16.67%-0.1
12.24%-0.43
-7.14%-0.15
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -10.40%9.9M10.61%7.92M29.58%8.73M25.51%33.79M4.01%8.85M82.31%11.05M18.43%7.16M6.72%6.73M2.63%26.92M14.13%8.51M
Selling and administrative expenses -40.71%3.11M-2.80%3.36M-6.64%2.98M41.25%15.68M6.20%3.79M129.19%5.24M26.06%3.46M22.79%3.2M-13.71%11.1M7.32%3.57M
-General and administrative expense -40.71%3.11M-2.80%3.36M-6.64%2.98M41.25%15.68M6.20%3.79M129.19%5.24M26.06%3.46M22.79%3.2M-13.71%11.1M7.32%3.57M
Research and development costs 16.92%6.79M23.16%4.56M62.28%5.74M14.76%17.71M-3.80%4.66M57.99%5.81M15.51%3.7M-4.56%3.54M19.44%15.43M31.61%4.84M
Depreciation amortization depletion ------------2.81%403K-----------------13.27%392K--99K
-Depreciation and amortization ------------2.81%403K-----------------13.27%392K--99K
Operating profit 10.40%-9.9M-10.61%-7.92M-29.58%-8.73M-25.51%-33.79M-4.01%-8.85M-82.31%-11.05M-18.43%-7.16M-6.72%-6.73M-2.63%-26.92M-14.13%-8.51M
Net non-operating interest income (expenses) -14.43%261K27.34%340K68.30%446K151.14%1.33M55.73%489K108.90%305K444.90%267K1,372.22%265K433.33%528K1,292.89%314K
Non-operating interest income -14.43%261K27.34%340K68.30%446K151.14%1.33M55.73%489K108.90%305K444.90%267K1,372.22%265K433.33%528K1,292.89%314K
Other net income (expenses) -87.03%107K183.63%419K4,231.25%1.39M192.40%4.81M1,569.97%4.45M-45.29%825K-154.05%-501K106.57%32K1,482.35%1.65M-9.48%-303K
Gain on sale of security -87.03%107K183.63%419K4,231.25%1.39M192.40%4.81M1,569.97%4.45M-45.29%825K-154.05%-501K106.57%32K1,482.35%1.65M-9.48%-303K
Income before tax 3.90%-9.53M3.15%-7.16M-7.10%-6.89M-11.73%-27.66M54.03%-3.91M-125.10%-9.92M-45.84%-7.39M5.04%-6.44M5.73%-24.75M-10.22%-8.5M
Income tax 71.43%12K102.13%95K15.48%97K-24.56%43K250.00%7K88.00%47K71.43%84K36.20%57K
Earnings from equity interest net of tax
Net income 3.85%-9.54M2.49%-7.26M-7.10%-6.89M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M5.58%-24.84M-10.36%-8.55M
Net income continuous operations 3.85%-9.54M2.49%-7.26M-7.10%-6.89M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M5.58%-24.84M-10.36%-8.55M
Noncontrolling interests
Net income attributable to the company 3.85%-9.54M2.49%-7.26M-7.10%-6.89M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M5.58%-24.84M-10.36%-8.55M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 3.85%-9.54M2.49%-7.26M-7.10%-6.89M-11.75%-27.75M53.83%-3.95M-125.16%-9.93M-46.05%-7.44M5.04%-6.44M5.58%-24.84M-10.36%-8.55M
Diluted earnings per share 14.29%-0.1216.67%-0.110.00%-0.094.65%-0.4166.67%-0.05-75.00%-0.14-33.33%-0.1216.67%-0.112.24%-0.43-7.14%-0.15
Basic earnings per share 14.29%-0.1216.67%-0.110.00%-0.094.65%-0.4166.67%-0.05-75.00%-0.14-33.33%-0.1216.67%-0.112.24%-0.43-7.14%-0.15
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data